Comments
Loading...
Tarsus Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:TARS | Benzinga
Tarsus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.730
Quarterly Revenue Estimate
$62.91M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$182.95M
Analyze the earnings history of Tarsus Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals | -$1.01 | -$0.73 | — | — | $27.61M | $62.91M | — | — | 05/07/2025 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$1.31 | -$0.82 | -$0.60 | 26.83% | $13.08M | $58.80M | $66.41M | 12.94% | 02/25/2025 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$1.28 | -$0.94 | -$0.61 | 35.11% | $1.87M | $43.44M | $48.12M | 10.77% | 11/13/2024 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$1.17 | -$0.93 | -$0.88 | 5.38% | $0.00 | $31.71M | $40.81M | 28.71% | 08/08/2024 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$0.88 | -$1.20 | -$1.01 | 15.83% | $2.50M | $17.83M | $27.61M | 54.87% | 05/08/2024 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$0.49 | -$1.36 | -$1.31 | 3.68% | $10.00M | $5.66M | $13.08M | 131.02% | 02/27/2024 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$0.84 | -$1.36 | -$1.28 | 5.88% | $0.00 | $400.00K | $1.87M | 367.75% | 11/09/2023 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$0.24 | -$1.08 | -$1.17 | -8.33% | $15.28M | — | $0.00 | — | 08/10/2023 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$0.98 | -$0.94 | -$0.88 | 6.38% | $539.00K | $3.12M | $2.50M | -19.87% | 05/09/2023 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$0.72 | -$0.69 | -$0.49 | 28.99% | $338.00K | $10.00M | $10.00M | 0.00% | 03/13/2023 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$0.76 | -$0.97 | -$0.84 | 13.40% | $1.24M | — | $0.00 | — | 11/09/2022 | Get Alert |
| TARS | Tarsus Pharmaceuticals | $0.29 | -$1.08 | -$0.24 | 77.78% | $22.02M | $13.00M | $15.28M | 17.52% | 08/11/2022 | Get Alert |
| TARS | Tarsus Pharmaceuticals | $0.47 | -$0.92 | -$0.98 | -6.52% | $33.43M | — | $539.00K | — | 05/10/2022 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$1.85 | -$0.73 | -$0.72 | 1.37% | $0.00 | $338.00K | $338.00K | 0.00% | 03/14/2022 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$3.71 | -$0.43 | -$0.76 | -76.74% | $0.00 | $5.33M | $1.24M | -76.74% | 11/09/2021 | Get Alert |
| TARS | Tarsus Pharmaceuticals | — | -$0.48 | $0.29 | 160.42% | — | $4.53M | $22.02M | 386.03% | 08/04/2021 | Get Alert |
| TARS | Tarsus Pharmaceuticals | -$0.74 | -$0.64 | $0.47 | 173.44% | — | $33.43M | $33.43M | 0.01% | 05/11/2021 | Get Alert |
| TARS | Tarsus Pharmaceuticals | — | -$0.66 | -$1.85 | -180.30% | — | — | $0.00 | — | 03/31/2021 | Get Alert |
| TARS | Tarsus Pharmaceuticals | — | — | -$3.71 | — | — | — | $0.00 | — | 11/25/2020 | Get Alert |
Tarsus Pharmaceuticals (TARS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $-0.60 | $-0.82 | 26.8 % |
| Q3 | 2024-11-13 | $-0.61 | $-0.94 | 35.1 % |
| Q2 | 2024-08-08 | $-0.88 | $-0.93 | 5.38 % |
| Q1 | 2024-05-08 | $-1.01 | $-1.20 | 15.8 % |
Tarsus Pharmaceuticals (TARS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $66.41M | $58.80M | 12.9 % |
| Q3 | 2024-11-13 | $48.12M | $43.44M | 10.8 % |
| Q2 | 2024-08-08 | $40.81M | $31.71M | 28.7 % |
| Q1 | 2024-05-08 | $27.61M | $17.83M | 54.9 % |
FAQ
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals (TARS) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
What were the latest earnings per share (EPS) for Tarsus Pharmaceuticals (NASDAQ:TARS)?
The Actual EPS was $-0.60, which beat the estimate of $-0.82.
What were Tarsus Pharmaceuticals’s (NASDAQ:TARS) revenues?
The Actual Revenue was $66.4M, which beat the estimate of $58.8M.
Browse earnings estimates, EPS, and revenue on all stocks.